Search research articles
Contact Us
Filters
Showing results (11-20 of 593) with videos related to
Page
of 60
Sort By:
Calcified Tissue International
|
February 1, 1992
Management of corticosteroid-induced osteoporosis: a clinician's perspective
S L Silverman
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
October 8, 2008
Paget disease of bone: therapeutic options
Stuart L Silverman
Endocrine
|
April 1, 1997
Nasal calcitonin
S L Silverman
Bone
|
January 1, 1992
The clinical consequences of vertebral compression fracture
S L Silverman
Annals of the New York Academy of Sciences
|
October 16, 2010
Bisphosphonate use in conditions other than osteoporosis
Stuart L Silverman
Current Osteoporosis Reports
|
December 17, 2010
Defining zoledronate's duration of action and optimal dosing interval for an effective therapy
Stuart L Silverman
Journal of Osteoporosis
|
October 29, 2010
Sclerostin
Stuart L Silverman
The Medical Clinics of North America
|
November 1, 1986
New diagnostic techniques in anatomic pathology
M L Silverman
Current Osteoporosis Reports
|
February 26, 2009
Zoledronic acid reduces recurrent clinical fracture in patients with hip fracture
Stuart L Silverman
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2009
Lessons from osteoporosis clinical trials
Stuart L Silverman
Page
of 60
Search research articles
Search
Showing results (11-20 of 593) with videos related to
Sort By:
Page
of 60
Calcified Tissue International
|
February 1, 1992
Management of corticosteroid-induced osteoporosis: a clinician's perspective
S L Silverman
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
October 8, 2008
Paget disease of bone: therapeutic options
Stuart L Silverman
Endocrine
|
April 1, 1997
Nasal calcitonin
S L Silverman
Bone
|
January 1, 1992
The clinical consequences of vertebral compression fracture
S L Silverman
Annals of the New York Academy of Sciences
|
October 16, 2010
Bisphosphonate use in conditions other than osteoporosis
Stuart L Silverman
Current Osteoporosis Reports
|
December 17, 2010
Defining zoledronate's duration of action and optimal dosing interval for an effective therapy
Stuart L Silverman
Journal of Osteoporosis
|
October 29, 2010
Sclerostin
Stuart L Silverman
The Medical Clinics of North America
|
November 1, 1986
New diagnostic techniques in anatomic pathology
M L Silverman
Current Osteoporosis Reports
|
February 26, 2009
Zoledronic acid reduces recurrent clinical fracture in patients with hip fracture
Stuart L Silverman
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 15, 2009
Lessons from osteoporosis clinical trials
Stuart L Silverman
Page
of 60